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Abstract 
Offspring of pregnancies affected by gestational diabetes mellitus (GDM) are at increased risk of 
developing type 2 diabetes. However, the extent to which these dysmetabolic traits may be due to 
offspring and/or maternal adiposity is unknown. 
Objective: We examined body composition and associated cardio-metabolic traits in 561 9-16 year 
old offspring of GDM and 597 control offspring. 
Research Design and Methods: We measured anthropometrics, puberty status, blood pressure, 
fasting glucose, insulin, C-peptide and lipids levels and dual energy X-ray (DEXA) scan in a subset 
of the cohort. Differences in the outcomes between GDM offspring and controls were examined 
using linear and logistic regression models. 
Results: After adjustment for age and gender, GDM offspring displayed higher weight, BMI, 
WHR, systolic blood pressure and resting heart rate and lower height. GDM offspring had higher 
total and abdominal fat percentages and lower muscle mass percentages, but these differences 
disappeared after correction for offspring BMI. GDM offspring displayed higher fasting plasma 
glucose, insulin, C-peptide, HOMA-IR and plasma triglycerides, whereas fasting plasma HDL-
cholesterol levels were decreased. Female GDM offspring had an earlier onset of puberty than 
control offspring. GDM offspring had significantly higher BMI, WHR, fasting glucose and HOMA-
IR after adjustment for maternal pre-pregnancy BMI, and glucose and HOMA-IR remained 
elevated in GDM offspring after correction for both maternal and offspring BMI.  
Conclusions: In summary, adolescent offspring of GDM women show increased adiposity, an 
adverse cardio-metabolic profile and earlier onset of puberty among girls. Increased fasting glucose 
and HOMA-IR among GDM offspring may be explained by programming effects of hyperglycemia 
in pregnancy. 
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Offspring of mothers with gestational diabetes (GDM) are at increased risk for developing obesity, 
insulin resistance and type 2 diabetes (1-4). Maternal obesity is one of the most important risk 
factors of both GDM and offspring adiposity, and the extent to which maternal obesity explains 
offspring adiposity and associated dysmetabolic traits independent of other factors including 
hyperglycaemia in pregnancy is controversial and the particular impact of hyperglycemia per se on 
offspring metabolic health is debated (5,6). Whereas intensified glucose lowering treatment of 
GDM women reduced macrosomia at birth, no beneficial  effect on offspring adiposity or 
associated cardio-metabolic dysfunctions at age 5-10 years was seen (7,8).  
Few studies have examined the impact of GDM on adiposity and insulin resistance during 
adolescence, and the joint influence of these factors on the onset of puberty. Early onset is 
associated with emotional challenges and can result in short stature, both of which may have 
influence at the individual and public health level. One study examined the impact of GDM on 
adiposity and metabolic variables across 5 puberty stages and found no difference in puberty 
development between GDM offspring and controls, but an increase in body fat percentages during 
all Tanner stages (9).  
Previous studies of GDM offspring have been variable size (n=24-1475 cases) with the largest 
studies having only few clinical measurements such as height, weight and weight to hip-ratio in the 
offspring (10,11). In the present study, we report clinical and metabolic characteristics including 
body composition and puberty status in a large cohort of 9-16 years old offspring of women with 
and without previous GDM recruited from the Danish National Birth Cohort (DNBC) (12). 
Additionally, we examine the association of GDM with offspring metabolic disease and puberty 
development while accounting for offspring and maternal degree of adiposity. 
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Research design and methods 
Subjects 
Participants were recruited from the DNBC that enrolled 91,827 primarily Caucasian women 
collectively contributing more than 100,000 pregnancies between January 1996 and October 2002 
as described in detail elsewhere (12). Briefly, data collection included 4 telephone interviews in 
gestation weeks 12 and 30, and 6 and 18 months postpartum. From the DNBC we included 1350 
women with a diagnosis of GDM and 2629 randomly selected controls and invited them and their 
offspring to participate in a clinical follow-up examination in 2012 March - 2014 April (13). In 
total, 608 (44%) case mother-offspring pairs and 626 (28%) control mother-offspring pairs 
participated. Main reason for non-participation was lack of time. We excluded multiple births 
including 33 twins (31 GDM), 3 triplets (all GDM) and only included the first sibling in our 
analyses (80 siblings in total, 40 kept in analyses) to avoid correlated measures. This left us with 
561 GDM offspring and 597 control offspring in our analyses (Figure 1). The offspring were 9-16 
years old at the time of examination. The study was approved by the Regional Scientific Ethics 
Committee for the municipalities of Copenhagen and Frederiksberg (H-4-2011-045 and H-4-2013-
129). Consent from both parents was essential for the participation of the child in the study. 
 
Diagnosis of GDM 
Initially, we used two different sources to identify women with a history of GDM. Women were 
classified with a diagnosis of GDM if they had responded positively to a question about GDM in at 
least one of the interviews conducted in gestation week 30 or 6 months postpartum, respectively. 
Furthermore, we used the Danish National Patient Register to extract information about diagnoses 
of GDM (ICD-10 classification: O244 and O249). Women with a self-reported diagnosis of GDM 
and/or an ICD-10 diagnosis and/or were classified as having had suspected GDM in our main 
analyses. Additionally, in sensitivity analyses we used an alternative diagnosis of GDM defined as 
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“best clinical judgement”. This diagnosis was based on a thorough review by two clinicians of 
hospital records of 96.5% of all GDM cases classified as described above. The ‘best clinical 
judgement” or verified GDM diagnosis was based upon several available data such as blood glucose 
measurements if available, or on other notes from the doctor indicating GDM. In the sensitivity 
analyses in the present paper, only those with GDM based upon the “the best clinical judgment” 
were included (n=332).     
In Denmark a risk factor based screening for GDM with a 75 g diagnostic oral glucose tolerance 
test (OGTT) was recommended during 1996-2002. If results from 75 g 3 hour OGTT was available 
from the hospital records, GDM was diagnosed if two or more glucose values exceeded the mean 
+3 SDs on a curve based on a group of 40 Danish healthy, nonobese, nonpregnant women without a 
family history of diabetes. However, in a few smaller departments the WHO criteria was used. The 
diagnosis of the GDM women is described in detail in (14). 
 
Clinical examinations: 
All participating offspring underwent a clinical examination that included anthropometric, 
metabolic and body composition measurements. Offspring were weighed without shoes and lightly 
dressed. We measured waist circumference at the level of umbilicus using a soft tape on standing 
subjects. Hip circumference was measured over the widest part of the gluteal region. After 10 
minutes, the resting blood pressure and heart rate were measured with an Omron blood pressure 
device in supine position. All measurements were taken twice and if the differences exceeded 0.5 
cm or 0.5 kg for the anthropometric measurements, or 5 mmHg for blood pressure measurements, a 
third measurement was taken. In all analyses, the mean value of the measurements was used. 
Offspring metabolic outcomes were obtained from a fasting blood sample that was taken during the 
clinical examination, and plasma, serum, buffy coat and whole blood (PAXgene) was collected. 
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Blood samples for glucose measurements were drawn in K-oxalat-Na-fluoride vials and in lithium-
heparin vials for insulin, C-peptide and lipid traits. All parameters were measured using standard 
laboratory methods on the Modular P-module (Roche, Mannheim, Germany). Coefficients of 
variance were 4 -5 % for glucose, insulin, total cholesterol, LDL cholesterol, HDL cholesterol, and 
triglycerides and 8 % for C-peptide. HOMA-IR was calculated as ([(Fasting plasma insulin (pmol/l) 
* fasting plasma glucose (mmol/l)) /22.5 ] *0.144) (15).   
In order to determine the puberty status of the study participants, clinical evaluations were made 
including pubertal staging of breast development and pubic hair for the girls according to Tanner’s 
classifications (16,17). Breast stage ≥B2 or girls pubic hair stage ≥PH2 was considered to be a 
marker of pubertal onset. Among the boys, a testicular volume of ≥4 ml, pubic hair stage ≥PH2 or 
boys genital stage ≥G2 was considered to be a marker of pubertal onset. A total of 238 GDM 
offspring and 256 control offspring agreed to have at least one of the Tanner score examinations 
performed. Finally, body composition outcomes were evaluated in a subset (n=637) of the offspring 
who had a dual energy x-ray (DEXA) scanning performed (GE Healthcare, Lunar Prodigy 
Advanced EnCore, including pediatric software).  
 
Statistical analyses 
Normally distributed, continuous outcomes were described using mean and standard deviation 
(SD), whereas median and inter quartile range (IQR) were used for skewed, continuous outcomes. 
Differences in anthropometric, metabolic, and body composition outcomes between offspring 
exposed to GDM and control offspring were examined using linear regression models. For normally 
distributed outcome variables, we calculated β coefficients and 95% confidence intervals (CIs) to 
estimate mean differences, whereas skewed variables were log-transformed and for these we 
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calculated % differences and 95% CIs. We used logistic regression models to analyze puberty status 
and calculated odds ratios (ORs) and 95% CIs.  
A priori we decided to first adjust for offspring age at the clinical examination and to analyze the 
age-adjusted estimates separately for boys and girls to investigate potential sex-specific differences. 
Because we did not see any marked differences between male and female offspring in the effect 
estimates, we decided to include offspring sex in our minimally adjusted model as a potential 
confounder rather than to stratify on sex. To examine whether observed cardio-metabolic 
differences were explained by the offspring’s own degree of adiposity, we included a model with 
adjusting for offspring BMI and one model with additional adjustment for offspring WHR. For 
those variables that remained statistically significantly different between GDM and control 
offspring after adjustment for offspring BMI and WHR, we subsequently conducted analyses in 
which we adjusted for maternal pre-pregnancy BMI (in categories <18.5 kg/m2, 18.5-24.99 kg/m2, 
25-29.99 kg/m2 and >=30 kg/m2). Maternal pre-pregnancy BMI was obtained from telephone 
interviews in gestation week 12. We did not adjust for other potential confounding variables, since 
our main aim was to determine if any observed differences were related to maternal obesity or 
hyperglycemia in pregnancy, rather than teasing out the contribution of a range of other potential 
confounding variables. 
In addition, we stratified for maternal pre-pregnancy BMI in four groups to examine if there were 
differences when comparing GDM offspring to controls across groups of maternal pre-pregnancy 
BMI. Additionally, we performed analyses in a sub-sample of women where GDM (N=332) was 
defined according to ‘best clinical judgement’ (14) compared to controls. 
 
Results 
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Table 1 presents the clinical characteristics of the offspring. There was an even sex distribution 
among case and control offspring, but control offspring were slightly older than GDM offspring at 
the time of follow-up, which was due to a time displacement for the examination time for some of 
the control offspring. When we adjusted for this age difference, GDM offspring were heavier and 
had a higher BMI, larger waist and hip circumferences, elevated WHR, as well as increased systolic 
blood pressure and heart rate compared to control offspring (Table 1). Furthermore, GDM offspring 
had higher fasting whole blood and fasting plasma glucose levels, as well as higher fasting plasma 
insulin, fasting C-peptide and HOMA-IR levels. In addition, the GDM offspring had an unhealthier 
plasma lipid profile with higher triglyceride and lower HDL levels. GDM offspring also had higher 
total fat percentages, more abdominal fat, and lower lean body mass percentages than control 
offspring. Among the female GDM offspring the odds of having reached puberty based on Tanner 
stage for breast development was almost doubled compared to control offspring. No differences in 
puberty development were observed between male GDM versus control offspring (Table 1). After 
adjustment for puberty status, we still observed significant differences in the insulin resistance 
markers between GDM and control offspring (data not shown).  
Since adiposity is one of the most important risk factors for insulin resistance, type 2 diabetes and 
cardiovascular disease (CVD) (18), we examined whether the adverse cardio-metabolic profile 
among GDM offspring was explained by their increased adiposity compared to controls. When 
adjusted for offspring BMI, GDM offspring still had significantly higher waist circumference, 
WHR, fasting plasma glucose, fasting insulin level and HOMA-IR levels (Table 2). Blood pressure, 
fasting C-peptide levels, lipid profile and data on body composition obtained from a DEXA scan 
were not significantly different between the two groups after adjustment for offspring BMI (Table 
2). In addition, the association with earlier onset of puberty among female GDM offspring was no 
longer significant after adjustment for the offspring’s own BMI (Figure 2). Adjusting for offspring 
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BMI Z-score instead of BMI did not change our results (data not shown). Additionally, GDM 
offspring displayed significantly higher fasting glucose (1.04 (1.02;1.05) p<0.0001) and HOMA-IR 
(1.09 (1.02;1.16) p=0.006) after further adjustment for WHR.  
As adiposity is highly heritable (19,20) we subsequently examined if the increased BMI, waist 
circumference and WHR together with the adverse metabolic profile among the GDM offspring 
could be explained by maternal obesity before pregnancy. After adjustment for maternal pre-
pregnancy BMI, GDM offspring still had higher BMI (Table 2). WHR, waist circumference, fasting 
glucose and HOMA-IR were all significantly higher in GDM offspring after further adjustment for 
both offspring BMI and maternal pre-pregnancy BMI (Table 2). Interestingly, the difference in the 
anthropometric, metabolic and body composition outcomes between GDM offspring and controls 
appeared to be stronger among offspring whose mothers were normal weight in pregnancy (18.5< 
BMI < 25) compared to overweight (BMI=25-30) or obese (BMI>30) (Table 3). Among obese 
mothers, no differences were observed between GDM offspring and controls.  
Finally, defining the GDM diagnosis using ‘best clinical judgement’ and only including offspring of 
hospital records GDM diagnosis resulted in similar or stronger associations, supporting our findings 
in all cases (supplementary table 1). 
 
Discussion 
We found that 9-16 year old offspring of GDM mothers had the following characteristics: 1) higher 
BMI, WHR, fat percentages and lower lean mass percentages, 2) increased fasting glucose, insulin 
and C-peptide, HOMA-IR, systolic blood pressure and triglycerides as well as reduced HDL-
cholesterol levels, and 3) female offspring had an earlier onset of puberty. Interestingly, after 
adjustment for the offspring’s own BMI and maternal pre-pregnancy BMI, GDM offspring still had 
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significantly higher fasting glucose, HOMA-IR and WHR, but differences in onset of puberty 
disappeared.  
Previous studies have shown that exposure to GDM was associated with higher BMI, waist 
circumferences and increased subscapular to triceps skinfold ratio (21), increased fat mass and 
central adiposity among GDM male offspring (22) and an increased risk of overweight and obesity 
among GDM offspring (11). In these studies, the associations between maternal hyperglycemia and 
offspring adiposity were attenuated but still significant after adjustment for maternal pre-pregnancy 
BMI. In adult offspring born to mothers with GDM, BMI was on average 0.94 kg/m2 greater than in 
their brothers born before the mother was diagnosed with diabetes suggesting that it is most likely 
due to intrauterine mechanisms and not familial confounding (10). A meta-analysis by Philipps et 
al. concluded that maternal diabetes was associated with increased offspring BMI z-score, but that 
this was no longer significant after adjustment for maternal pre-pregnancy BMI (6). However, only 
five studies had data available on maternal pre-pregnancy BMI and four of these were based on 
small sample sizes, and the adjusted analyses were made on all diabetic pregnancies and not only 
pregnancies affected by GDM. Others studies have found increased total fat percentages and 
increased lean mass measured by DEXA scans in prepubertal offspring of mothers with GDM; 
however, in these studies no adjustment for offspring BMI or maternal pre-pregnancy BMI was 
made (23,24). Taken together, our study highlights the importance of adjusting for maternal pre-
pregnancy BMI when analysing the impact of maternal hyperglycemia in pregnancy on offspring’s 
degree of obesity.  We a priori chose not to include birth weight in our analyses since we considered 
birthweight as a mediator of the association between GDM and later risk of obesity among the 
offspring. However, if we adjusted for birthweight there was still a significant difference between 
GDM and control offspring with regards to adiposity measurements such as BMI, waist 
circumference, total fat percentages and gynoid and android fat while birthweight per se 
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independently was associated with offspring BMI and waist circumference but not with DEXA 
(data not shown)”.  
 
Our finding of higher systolic blood pressure in GDM offspring was also observed in 3 years old 
offspring, where after adjustment for the offspring’s skinfold thicknesses, the association between 
GDM and increased systolic blood pressure was no longer significant (25). Similar to our findings, 
a meta-analysis showed that GDM offspring had higher systolic blood pressure, but no difference in 
diastolic blood pressure as compared with control offspring was observed. However, all these 
studies had smaller GDM offspring samples, no adjustment for offspring BMI and no significant 
association between offspring systolic blood pressure and maternal pre-pregnancy BMI was found 
in five of the studies were data on maternal pre-pregnancy BMI was available (26). In contrast, in 3-
17 year old GDM offspring no association between GDM and offspring blood pressure was found 
(27). However, the latter study included a smaller sample size and the GDM diagnosis was based 
upon one single question on a questionnaire. 
Our findings of multiple early disturbances in the cardio-metabolic system in offspring of GDM 
pregnancies are in line with previous smaller studies. However, not all previous studies adjusted the 
disturbances in the cardio-metabolic traits for the offspring’s own degree of adiposity (1,3,28). 
Similar to our results other studies adjusted for offspring BMI and reported an attenuation, but still 
significant association, of the impact of GDM on offspring insulin insensitivity and risk of future 
type 2 diabetes (29,30). One study showed that adult offspring born to women with GDM had 
reduced insulin sensitivity compared to offspring from the background population, also after 
adjusting for sex and overweight (2). Holder et al. followed obese adolescents for an average of 2.8 
years and found that insulin sensitivity at follow-up were significantly lower in the group that had 
been exposed to GDM (n=45) in utero after adjusting for offspring BMI (31). Additionally, others 
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have found that greater maternal glucose concentration in pregnancy was associated with reduced 
insulin sensitivity and greater static beta cell response after a meal tolerance test in 21 pre-pubertal 
children, independent of the children’s own fat percentages measured by DXA scanning (32). In the 
present study we found that the C-peptide levels were no longer significantly different between 
GDM and control offspring after adjustment for offspring BMI, whereas fasting insulin levels 
remained significant. We speculate that the difference in levels of statistical significance represents 
variations of the assays used rather than biologically important differences in insulin and C-peptide 
kinetics. Indeed, the confidence interval for C-peptide was substantially larger than the confidence 
interval for insulin. Alternatively, the relatively increased plasma insulin compared with plasma C-
peptide levels among GDM offspring could reflect lower insulin clearance as a result of insulin 
resistance. C-peptide is cleared by the kidneys and therefore not influenced by insulin resistance 
(33). 
 
We found that the probability of having reached puberty assessed by breast development, 
considered the golden standard for evaluating puberty onset and development among girls (34), was 
doubled among offspring of GDM mothers. In contrast, others showed no differences in Tanner 
stages among GDM and non-GDM offspring in analyses when boys and girls were analyzed 
together (35). One study showed that GDM was associated with a two months earlier transition to 
Tanner stage ˃2 examined by pubic hair development among boys (36). However, these studies did 
not adjust for offspring BMI. There is a general agreement that a higher fat mass or higher BMI 
among girls is associated with an earlier onset of puberty (37,38), which supports our results that 
the earlier onset of puberty among GDM female offspring is mainly driven by the offspring’s BMI 
and emphasizing the importance of adjusting for offspring adiposity when addressing the impact of 
hyperglycemia on puberty development. 
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Our results stratifying on maternal pre-pregnancy BMI, suggest that hyperglycemia may be more 
relevant in the absence of severe maternal adiposity, i.e. the impact of hyperglycemia on offspring’s 
body composition may be overruled by severe obesity in the mother. This is in accordance to a 
recent study, also based on the DNBC, showing that the effect of maternal fasting plasma glucose in 
pregnancy on offspring obesity at 7 year, appeared more pronounced among non-obese GDM 
women compared with obese GDM women (39). However, more studies are needed to understand 
the separate role and the combined potential superimposing effect of maternal hyperglycemia and of 
maternal obesity during pregnancy, on their offspring metabolic health. 
Besides maternal obesity and hyperglycemia, other factors such as paternal obesity influence the 
offspring’s level of obesity and adiposity. The strengths of this study included a large sample of 
GDM pregnancies and good statistical power to examine long-term consequences of intrauterine 
hyperglycemia in this longitudinal study with more than ten years of follow-up. Detailed data were 
available on body composition, cardio-metabolic factors, and clinical assessments of puberty onset 
in the offspring, allowing for more precise phenotypical characterization. Since puberty is, among 
other factors, characterized by insulin resistance (40), it is an enormous strength in the present study 
that we can take the stage of pubertal development into account.  
The present study had some limitations. The GDM group contained both confirmed and suspected 
cases and may therefore have included women without GDM. Nonetheless, a sensitivity analysis of 
groupings based on clinician’s best judgement in a subsample of the women did not alter the results. 
Another limitation is that a few smaller departments used the WHO criteria and not the commonly 
used Danish criteria for GDM. While detailed clinical data was available for the offspring, 
comparable information was not available for mothers or fathers for the relevant time period. For 
example, no detailed measures of maternal body composition were available for the pre-pregnancy 
period, and no data on paternal health was available to account for any genetic predisposition. 
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However, the explained genetic variance for most complex diseases is ≤10% and thus the impact on 
our results may not have been substantial. Misclassification of reported maternal BMI is likely to 
have been more prevalent at higher BMI values, and may have underestimated the frequencies in 
overweight and obese categories. This would have led to residual confounding in the models 
adjusting for maternal BMI. We also lacked data on postnatal environment, and possible shared 
social and familial obesogenic risk factors such as diet. Dietary information for both parents and 
offspring was not available until teen years. Although parental and offspring diets during this time 
period were only weakly correlated (Bjerregaard A.A, preliminary data), we cannot exclude that 
stronger correlations existed earlier in childhood. Our data on puberty may also be subjective to 
selection bias, since the boys and girls that did not want to participate in the puberty examination, 
were often also those that were older and had attained puberty. Since the DEXA scanning was only 
available at the Copenhagen University Hospital, it was only offspring examined at this location 
that was offered a DEXA scan. This may have caused some bias, since the mothers of offspring 
with a DXA scan were older, had higher socio economic status and lower pre-pregnancy BMI. 
However, these differences were similar for the two exposure groups, which suggest that any 
present bias may be minor. Furthermore, we cannot exclude that our results to some extent may be 
due to other confounding factors such as socio-economic status or breastfeeding duration, rather 
than hyperglycemia and maternal obesity per se. 
 
In conclusion, we demonstrated that 9-16 year old offspring of GDM mothers had higher BMI, 
WHR and higher fat percentage with more abdominal obesity, higher systolic blood pressure, 
fasting glucose, insulin and C-peptide levels and higher HOMA-IR and an earlier onset of puberty 
among girls. The association to higher blood pressure, higher fasting C-peptide levels, adverse lipid 
profile and earlier onset of puberty seemed driven by the offspring’s own BMI, whereas GDM 
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offspring still had higher WHR, fasting glucose and HOMA-IR even after adjustment for both the 
offspring’s own BMI and maternal pre-pregnancy BMI. This supports an independent role of 
hyperglycemia in pregnancy programming body composition as well as insulin resistance among 
adolescent offspring.   
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Figure legends 
Figure 1. 
Flow chart of enrolment and examination of women and children in the Diabetes and Women’s Health 
Study.  
 
Figure 2. 
Differences in offspring puberty status comparing GDM offspring to control offspring. Odds ratios are 
adjusted for offspring BMI 
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Table 1. Anthropometric, metabolic, body composition, and puberty characteristics of GDM offspring and 
controls at age 9-16 years. 
 
For the crude estimate data are presented as mean (SD) or median* (IQR) for normally and non-normally distributed variables, 
respectively.  
When data area adjusted for age and sex they are presented as either mean difference, when the residuals are normal distributed, and 
as % difference when data are log transformed. 
aP-values calculated using Student’s T-test, Kruskal Wallis test*, or Chi-square tests. 
ϒ Values are n (%) and adjusted estimates are odds ratios (95% CI) and are only adjusted for age.  
 Pb: age and sex adjusted measurements comparing GDM to control offspring 
Android tissue % fat: Located in the abdominal area 
Gynoid tissue fat %: Located around the hips 
 
 
 
  Crude measurements  Age and sex adjusted 
estimates 
 
 GDM offspring Control offspring  Pa Mean difference or 
% difference* (95% 
CI) 
Pb 
Anthropometric characteristics  N=546-561 N=590-597    
      
   Age (years) 12.1 (1.5) 12.8 (1.5) <0.001   
   Sex (boys) 295 (52.6%) 301 (50.4%) 0.68   
   Weight (kg) 48.5 (12.7) 47.2 (12.1) 0.08 4.66 (3.48, 5.84) <0.001 
   Height (cm) 156.8 (11.4) 159.5 (11.4) <0.001 1.15 (0.27, 2.03) 0.01 
   BMI (kg/m2)* 18.8 (4.2) 17.9 (3.4) <0.001 9% (7-11%) <0.001 
   Waist (cm) 73.3 (10.6) 69.9 (8.4) <0.001 4.92 (3.87, 5.98) <0.001 
   Hip circumference (cm) 83.8 (9.6) 82.7 (9.3) 0.07 3.47 (2.55, 4.39) <0.001 
   Waist hip ratio (WHR) 0.87 (0.06) 0.85 (0.05) <0.001 0.02 (0.01;0.03) <0.001 
   Head circumference (cm) 55.8 (2.1) 55.5 (2.2) 0.18 0.51 (0.28, 0.75) <0.001 
   Systolic blood pressure (mmHg) 109.7 (8.6) 109.5 (8.6) 0.75 1.04 (0.06, 2.01) 0.04 
   Diastolic blood pressure (mmHg) 62.5 (6.0) 62.6 (6.1) 0.84 -0.20 (-0.92, 0.51) 0.58 
   Heart rate (BPM) 69.7 (2.1) 68.1 (10.0) 0.001 0.81 (-0.34, 1.96) 0.17 
      
Metabolic characteristics N=468-522 N=508-559    
   Whole blood fasting glucose (mmol/l)* 4.7 (0.8) 4.5 (0.7) <0.001 3% (1-5%) 0.001 
   Fasting plasma glucose (mmol/l)* 5.0 (0.8) 4.8 (0.6) <0.001 4% (3-6%) <0.001 
   Fasting insulin (pmol/l)* 69.4 (47.3) 61.3 (34.7) 0.001 17% (10-24%) <0.001 
   Fasting C-peptide (pmol/l) 596 (211) 575 (189) 0.05 51 (28,74) <0.001 
   HOMA-IR* 2.2 (1.6) 1.9 (1.1) <0.001 21% (14-30%) <0.001 
   Triglycerides (mmol/l)* 0.73 (0.4) 0.70 (0.4) 0.58 5% (1-10%) 0.04 
   HDL cholesterol (mmol/l) 1.5 (0.4) 1.6 (0.4) 0.11 -0.07 (-0.11, -0.02) 0.004 
   LDL cholesterol (mmol/l) 2.4 (0.7) 2.3 (0.6) 0.08 0.06 (-0.01, 0.14) 0.11 
   Total cholesterol (mmol/l) 4.3 (0.7) 4.2 (0.7) 0.22 0.03 (-0.05, 0.12) 0.47 
      
Body composition measured by DXA N=191 N=446    
   Total fat % 31.2 (8.1) 27.0 (7.0) <0.001 3.45 (2.22, 4.69) <0.001 
   Total lean mass % 66.2 (7.5) 70.1 (6.5) <0.001 -3.21 (-4.37, -2.07) <0.001 
   Total android tissue % fat* 25.6 (20.1) 19.4 (13.8) <0.001 22% (12-33#) <0.001 
   Total gynoid tissue % fat 35.3 (8,3) 31.2 (7.8) <0.001 2.98 (1.71, 4.25) <0.001 
   Fat distribution (android/gynoid ratio) 0.73 (0.2) 0.66 (0.18) <0.001 0.08 (0.05, 0.12) <0.001 
   Total bone mass density (mg/cm2)  0.9 (0.1) 1.0 (0.1) <0.001 0.02 (0.001, 0.03) 0.04 
      
Puberty status N=192-238ϒ N=176-256 ϒ    
   Girls breast stage (n yes ≥B2, %) 141 (59.2%) 169 (66.0%) 0.18 1.99 (1.18, 3.34) 0.01 
   Girls pubic hair (n yes ≥ PH2, %) 99 (44.8%) 133 (56.1%) 0.06 1.51 (0.90, 2.55) 0.12 
   Boys testis size (n yes ≥ 4 ml, %) 143 (74.5%) 156 (85.7%) 0.02 0.77 (0.42, 1.41) 0.40 
   Boys pubic hair (n yes≥ PH2, %) 50 (24.3%) 60 (29.6%) 0.02 1.74 (0.92, 3.28) 0.09 
   Boys genital stage (n yes≥ G2, %) 63 (32.6%) 66 (37.5%) 0.07 1.24 (0.72, 2.14) 0.45 
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Table 2. Differences in offspring anthropometric and metabolic characteristics comparing GDM offspring to 
controls after adjustment for offspring age, sex and BMI and maternal pre-pregnancy BMI 
 
*non-normally distributed variables 
Pc adjusted for age sex and offspring BMIPd adjusted for age sex and offspring BMI and maternal pre-pregnancy BMI    # adjusted for 
age sex and maternal pre-pregnancy BMI  Only variables that were significant after adjustment for offspring BMI were further 
adjusted for maternal pre-pregnancy BMI
Offspring outcomes     
 Mean difference or % 
difference* (95% CI) 
Pc Mean difference or % 
difference* (95% CI) 
Pd 
Anthropometric characteristics     
   BMI (kg/m2)# - - 4% (2-6%) <.0001 
   Waist circumference (cm) 0.83 (0.30;1.35) 0.002 0.52 (-0.06;1.08) 0.08 
   Hip circumference (cm) 0.01 (-0.48;0.49) 0.97 - - 
   Waist hip ratio (WHR) 0.009 (0.003;0.02) 0.002 0.009 (0.002;0.02) 0.01 
   Head circumference (cm) 0.17 (-0.05;0.40) 0.13 - - 
   Systolic blood pressure (mmHg) 0.30 (-0.70;1.30) 0.55 - - 
   Diastolic blood pressure (mmHg) -0.63 (-1.26; 0.11) 0.09 - - 
   Heart rate (BPM) 0.82 (-0.37;2.02) 0.17 - - 
Metabolic characteristics     
   Whole blood fasting glucose 
(mmol/l)* 
2% (1-4%) 0.02 2% (1-4%) 0.02 
   Fasting plasma glucose (mmol/l)* 4% (1-5%) <.0001 4% (2-5%) <.0001 
   Fasting Insulin (pmol/l)* 7% (1-13%) 0.04 4% (-2-11%) 0.18 
   C-peptide (pmol/L) 8.7 (-13;30) 0.43 - - 
   HOMA-IR* 11% (4-18%) 0.002 8% (1-16%) 0.02 
   Triglycerides (mmol/l)* 0% (-5-5%) 0.92 - - 
   HDL cholesterol (mmol/l) -0.02 (-0.07;0.02) 0.30 - - 
   LDL cholesterol (mmol/l) 0.003 (-0.07;0.08) 0.93 - - 
   Total cholesterol (mmol/l) -0.002 (-0.09;0.09) 0.96 - - 
Body composition measured by DXA     
   Total fat % 0.72 (-0.17;1.61) 0.11 - - 
   Total lean mass % -0.70 (-1.54;0.14) 0.10 - - 
   Total android tissue % fat* 2% (-4-8%) 0.50 - - 
   Total gynoid tissue % fat 0.56 (-0.48;1.59) 0.29 - - 
   Fat distribution (android/gynoid ratio) 0.005 (-0.02;0.03) 0.66 - - 
   Total bone mass density (mg/cm2)  -0.007 (-0.02;0.007) 0.30 - - 
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Table 3. Age and sex-adjusted mean differences or % differences* (95 % CI) for offspring characteristics across groups of maternal pre-pregnancy BMI 
comparing GDM offspring to controls. 
 
 N Maternal pre-pregnancy 
BMI <18.5 
 N Maternal pre-pregnancy 
BMI 18.5-<25 
 N Maternal pre-pregnancy 
BMI 25-<30 
 N Maternal pre-pregnancy 
BMI ≥30 
 
  Mean difference or % 
difference * (95% CI) 
p  Mean difference or % 
difference * (95% CI) 
p  Mean difference or % 
difference * (95% CI) 
p  Mean difference or % 
difference * (95% CI) 
p 
Anthropometric characteristics             
Weight (kg) 44 -2.04 (-7.64, 3.55) 0.46 646 3.24 (1.79, 4.70) <0.001 233 1.34 (-1.63, 4.31) 0.37 180 1.43 (-2.86, 5.73) 0.51 
Height (cm) 44 -2.63 (-9.01, 3.75) 0.41 646 1.56 (0.36, 2.76) 0.01 234 -0.63 (-2.78, 1.52) 0.57 180 -0.08 (-2.97, 2.80) 0.95 
BMI (kg/m2)* 44 -2% (-12-9%) 0.72 646 5% (3-7%) <0.001 234 4% (-1-9%) 0.12 180 3% (-3-10%) 0.34 
Waist (cm) 44 1.34 (-4.32, 7.00) 0.63 645 2.66 (1.51, 3.82) <0.001 232 3.00 (0.22, 5.78) 0.03 180 2.25 (-1.86, 6.37) 0.28 
Hip circumference (cm) 44 -1.74 (-5.90, 2.41) 0.40 646 1.80 (0.66, 2.94) 0.002 233 1.18 (-1.07, 3.43) 0.30 179 1.68 (-1.61, 4.97) 0.32 
Head circumference (cm) 44 -1.14 (-2.43, 0.15) 0.08 644 0.42 (0.08, 0.76) 0.01 230 0.53 (0.03, 1.03) 0.04 179 -0.22 (-0.98, 0.55) 0.58 
Systolic blood pressure (mmHg) 44 -0.29 (-7.62,  7.04) 0.94 645 1.56 (0.16, 2.97) 0.03 231 -0.54 (-2.74, 1.65) 0.63 178 -0.75 (-3.80, 2.30) 0.63 
Diastolic blood pressure (mmHg) 44 0.68 (-4.00, 5.36) 0.77 644 -0.34 (-1.37, 0.70) 0.53 231 0.06 (-1.50, 1.62) 0.94 178 -1.22 (-3.54, 1.09) 0.30 
Heart rate (BPM) 44 8.87 (-1.48, 19.22) 0.09 640 0.33 (-1.27, 1.93) 0.69 227 1.94  (-0.74, 4.62) 0.16 174 -1.26 (-4.87, 2.34) 0.49 
Metabolic characteristics             
Whole blood fasting glucose (mmol/l)* 44 2% (-2-16%) 0.79 609 2% (1-5%) 0.07 222 4% (1-8%) 0.02 165 1% (-3-6%) 0.57 
Plasma glucose (mmol/l)* 41 -3% (-12-6%) 0.46 574 4% (2-6%) 0.0001 210 4% (1-7%) 0.01 156 1% (-3-5%) 0.64 
C-peptide (pmol/l) 40 155 (-4, 313) 0.06 572 26 (-5, 57) 0.10 213 -5 (-62, 52) 0.87 154 43 (-33, 119) 0.26 
Insulin (pmol/l)* 39 10% (-14-59%) 0.60 559 11% (2-21%) 0.02 204 -1% (-13-13%) 0.99 150 19% (-1, 43%) 0.06 
Triglycerides (mmol/l)* 40 5% (-17-51%) 0.79 573 5% (-1-11%) 0.12 214 -6% (-17-6%) 0.29 154 8% (-8-27%) 0.36 
HOMA-IR* 39 9% (-27-62%) 0.68 551 15% (5-26%) 0.002 201 3% (-11-19%) 0.68 148 22% (-1-50%) 0.06 
HDL cholesterol (mmol/l) 40 -0.10 (-0.41, 0.20) 0.50 573 -0.03 (-0.10, 0.03) 0.30 214 -0.03 (-0.14, 0.08) 0.57 154 -0.01 (-0.15, 0.12) 0.84 
LDL cholesterol (mmol/l) 40 0.02 (-0.51, 0.55) 0.94 573 0.02 (-0.09, 0.12) 0.76 214 0.13 (-0.07, 0.33) 0.19 154 0.03 (-0.23, 0.28) 0.84 
Total cholesterol (mmol/l) 40 -0.01 (-0.64, 0.61) 0.97 573 0.001 (-0.12, 0.12) 0.98 214 0.15 (-0.07, 0.36) 0.18 154 -0.01 (-0.29, 0.26) 0.93 
Body composition             
Total fat % 36 1.11 (-7.29, 9.50) 0.79 393 2.03 (0.42, 3.64) 0.01 113 1.34 (-1.63, 4.30) 0.37 69 0.43 (-3.58, 4.43) 0.83 
Lean mass % 36 -0.98 (-8.73, 6.77) 0.80 393 -1.91 (-3.40, -0.41) 0.01 113 -1.26 (-4.01, 1.50) 0.37 69 -0.47 (-4.19, 3.25) 0.80 
Total android tissue % fat* 36 6% (-43-97%) 0.85 393 12% (1-26%) 0.06 113 3% (-14-24%) 0.74 69 1% (-19-26%) 0.94 
Total gynoid tissue % fat 36 0.69 (-8.02, 9.41) 0.87 393 1.69 (-0.07, 3.45) 0.06 113 0.72 (-2.19, 3.63) 0.63 69 0.20 (-3.50, 3.90) 0.92 
Fat distribution (android/gynoid ratio) 36 0.06 (-0.17, 0.28) 0.60 393 0.05 (-0.004, 0.09) 0.05 113 0.02 (-0.06, 0.10) 0.57 69 0.004 (-0.09, 0.10) 0.94 
Total bone mass density (mg/cm2) 36 -0.04 (-0.14, 0.06) 0.44 393 0.01 (-0.01, 0.03) 0.45 113 0.001 (-0.03, 0.04) 0.96 69 0.01 (-0.04, 0.05) 0.79 
